Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 146 NIH 63 NETWORK 48 INDUSTRY 38 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 48 Capecitabine 41 Gemcitabine 33 apatinib 32 Oxaliplatin 32 Cyclophosphamide 31 Radiotherapy 29 Paclitaxel 29 Carboplatin 29 tislelizumab 27 Irinotecan 27 Drug Therapy 27 Fluorouracil 26 Docetaxel 26 Bevacizumab 23 fludarabine 18 Nivolumab 17 pembrolizumab 16 Surgical Procedures, Operative 16 Exercise 16 Metformin 15 S 1 (combination) 14 camrelizumab 13 Radiation 13 Pemetrexed 13 Control Groups 12 anlotinib 11 Leucovorin 11 Vinorelbine 10 Standard of Care 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × Daunorubicin × Clear all

NCT02416388 2024-08-07

BIG-1

University Hospital, Angers

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡